Dr. Raymond Laboratories, Inc.

Neopharm Co., Ltd.

Byeong Deog Park

Se Kyoo Jeong

Chae Hyeong Park

Yong Zu Kim

Sung Ho Woo

Hyang Sook Lee

Tae Kyo Park

Dae Yon Lee

Jeong Eun Jeon

Joung Yul Yun

Kyungho Park

Kyong Oh Shin

Sin Hee Lee

Hyung Sub Gwak

Hyung Mook Choi

Uk Il Kim

Disclosed herein is a method for predicting or diagnosing psychiatric disorders through analyzing skin tissues samples minimally invasive or non-invasively collected. The method disclosed herein makes it possible to diagnose psychiatric disorders through objective biomarkers at a very early age, without giving pain to subjects because of noninvasive or minimally invasive feature of skin sample collection method.

Method for diagnosing psychiatric disorders

The present invention relates to a composition for skin external application. Specifically, a composition for skin external application comprising a stably formed lamella liquid crystal phase can be provided according to the present invention. In addition, according to the present invention, the composition can provide excellent skin moisturizing and skin barrier strengthening effects upon application on the skin, as well as act effectively as an agent for a cannabinoid type 1 receptor, such that it is expected that the present invention can provide a very effective effect for treatment or improvement of skin diseases and mental disorders associated with skin diseases.

Composition for skin external application

An autophage activating resveratrol topical composition includes a ceramide or a pseudoceramide, a fatty acid, a phytosterol, and a resveratrol. The ceramide or pseudoceramide, the fatty acid, the phytosterol, and the resveratrol form a multi-layered encapsulation system. A method of inducing autophagy in skin includes applying the autophage activating resveratrol topical composition to a skin, and inducing autophagy in the skin to improve skin barrier function and skin self-purification function.

Autophage activating resveratrol topical composition for skin improvement and treatment

Provided are heterocyclic compounds, having effects of treating and preventing inflammatory diseases and treating skin wounds, and particularly, exhibiting effects of recovering disrupted skin barriers, mitigating inflammation, and pruritus. Also, a composition containing the compound as an effective component can be used to mitigate various inflammatory diseases and protease activated receptor-2 (PAR-2)-overexpressed diseases, and can be particularly used as a composition having an anti-inflammatory function in inflammatory skin diseases including atopic dermatitis and the like, by inhibiting PAR-2 activity.

Heterocyclic compound, and composition for treating inflammatory diseases using same

Growing community of inventors

Daejeon, South Korea

Byeong Deog Park